These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 35256932)

  • 1. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.
    Austad SN; Ballinger S; Buford TW; Carter CS; Smith DL; Darley-Usmar V; Zhang J
    Acta Pharm Sin B; 2022 Feb; 12(2):511-531. PubMed ID: 35256932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria in innate immune signaling.
    Banoth B; Cassel SL
    Transl Res; 2018 Dec; 202():52-68. PubMed ID: 30165038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How autophagy controls the intestinal epithelial barrier.
    Foerster EG; Mukherjee T; Cabral-Fernandes L; Rocha JDB; Girardin SE; Philpott DJ
    Autophagy; 2022 Jan; 18(1):86-103. PubMed ID: 33906557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging views of mitophagy in immunity and autoimmune diseases.
    Xu Y; Shen J; Ran Z
    Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial complex I as a therapeutic target for Alzheimer's disease.
    Trushina E; Trushin S; Hasan MF
    Acta Pharm Sin B; 2022 Feb; 12(2):483-495. PubMed ID: 35256930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
    Jayaraj RL; Azimullah S; Beiram R
    Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression.
    Wang Q; Bu Q; Liu M; Zhang R; Gu J; Li L; Zhou J; Liang Y; Su W; Liu Z; Wang M; Lian Z; Lu L; Zhou H
    JHEP Rep; 2022 Nov; 4(11):100555. PubMed ID: 36185574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gasdermin D in pyroptosis.
    Burdette BE; Esparza AN; Zhu H; Wang S
    Acta Pharm Sin B; 2021 Sep; 11(9):2768-2782. PubMed ID: 34589396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
    Larabi A; Barnich N; Nguyen HTT
    Autophagy; 2020 Jan; 16(1):38-51. PubMed ID: 31286804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen: a master regulator of bioenergetic systems in the brain and body.
    Rettberg JR; Yao J; Brinton RD
    Front Neuroendocrinol; 2014 Jan; 35(1):8-30. PubMed ID: 23994581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
    Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
    Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7/IRF3 activation to aggravate lung injury during severe acute pancreatitis.
    Peng Y; Yang Y; Li Y; Shi T; Xu N; Liu R; Luan Y; Yao Y; Yin C
    Cell Mol Biol Lett; 2024 Apr; 29(1):61. PubMed ID: 38671352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
    Yao RQ; Ren C; Xia ZF; Yao YM
    Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.